Skip to content
Low DoseGLP-1Providers

Provider review

SnagRx review

Same price no matter the dose, said three times.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.

$99/mo flat at every dose

Visit SnagRx

A quarter dose costs what a full dose costs; SnagRx is not ambiguous about it. The advertised rate is the twelve-month rung, and month to month runs over 40% higher on semaglutide.

Price as published

SnagRx

$99/mo flat at every dose

Vs median
$76/mo below the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Same price at every dose
Dispensed
Pharmacy not publicly identified
Visit SnagRx

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

On this page (9)
  1. The verdict
  2. Who it suits, and who it does not
  3. What it actually costs
  4. What is included
  5. Pharmacy, labs and oversight
  6. How the program works
  7. The honest cons
  8. How it compares
  9. Read this before you buy

In one paragraph

The verdict

Take a quarter dose here and you pay what a full dose costs. SnagRx says "Same price no matter the dose" in its running header, in its plan bullets and in its hero — there is no ambiguity to exploit, and no low-dose product to move to. Credit for the part that matters most: it publishes the whole billing-cycle table, one, three, six and twelve months side by side, so the standing rate is recoverable rather than buried behind the cheap one. It also names the two states it cannot serve and gives the regulatory reason. Three things will cost you. The figure splashed across the homepage is the twelve-month rate, and month to month is well over 40% higher on semaglutide. The countdown labeled "Price increases in" is served already at zero. And its published tirzepatide protocol carries garbled units at a starting figure far above the standard one — worth querying before you inject anything.

Visit SnagRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You want the whole term ladder published so you can see what you would pay without committing
  • You are starting low and expect to climb, and want the rate to stay put while you do
  • You want to know upfront which states cannot be served, and why
  • You are prepared to commit to a year, which is what the advertised rate requires

Look elsewhere if

  • You are taking less to spend less. This is the structure that bills a quarter dose at the full-dose rate
  • You are budgeting from the homepage figure. That is the twelve-month rung; month to month is well over 40% higher on semaglutide
  • You take the countdown as real — its digits are served already at zero
  • You are relying on its published tirzepatide titration schedule. The units are garbled and the starting figure sits far above the standard one
  • You live in Mississippi or Louisiana

What it actually costs

Price as published

$99/mo flat at every dose

Vs median
$76/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
Market
$59–$1,300/mo is the full published spread on this site
Structure
Same price at every dose

One stated price across doses. A lower dose does not automatically reduce the bill. Compare the complete medication, membership, laboratory and shipping quotes before assuming another plan costs less.

113 of the 548 programs here price a small dose this way. The flat basis is stated three times over and the discount attaches to the length of the term rather than the dose, so nothing about taking less reduces the bill. The published billing-cycle table does at least make the standing rate recoverable, unlike most of the category.

See SnagRx's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not confirmed
Labs
Not required
Pricing
Flat at every dose

What it does well

  • Publishes the whole billing-cycle table — one, three, six and twelve month rates side by side — instead of only the cheapest rung, so the standing rate is recoverable
  • "Same price no matter the dose" appears in the running header, the plan bullets and the hero, so the structure cannot be misread
  • Names the two states it cannot serve and gives the regulatory reason
  • Lists "Transparent pricing — no surprise fees as your dose changes" among what the plan includes
  • Explains the 503A framework accurately, including USP 795/797 and state board licensure

Start with SnagRx

Pharmacy, labs and oversight

SnagRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Transparency check

3 of 4 published openly

What SnagRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
Not published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
Published
What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
Published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

SnagRx sells compounded semaglutide and compounded tirzepatide as a monthly plan at one rate per molecule, with the discount tied to the length of term you commit to rather than to the dose you take. It publishes the whole billing-cycle table — one, three, six and twelve months side by side, under a heading of that name — which is what makes the true month-to-month rate recoverable rather than hidden behind the cheapest rung. Its dose basis is stated repeatedly and unambiguously: "Same price no matter the dose." It explains the 503A framework accurately, including USP 795/797 and state board licensure, without naming a pharmacy, and it names the two states it cannot serve and the regulatory reason.

See how SnagRx works

The honest cons

ONE PRICE AT EVERY DOSE. A patient holding at a quarter dose pays exactly what a full-dose patient pays, and no low-dose product is published to move to instead
  • The $69/month splashed across the homepage is the twelve-month prepay rate. Month to month is $99 — 43% higher. Tirzepatide is advertised at $119 against $149 month to month
  • The homepage countdown labeled "Price increases in" is served with its digits already at 00: 00: 00: 00
  • The published tirzepatide protocol reads "10/mg for the first 4 weeks / 20/mg for the next 8 weeks" — the units are garbled, and 10 mg a week would be an unusually high start against a standard compounded starting dose of 2.5 mg
  • Three mutually inconsistent discount claims run across two pages: "Was $299", "Summer Start Promo Applied. Save $230 Every Month" and "Get $450 OFF your prescription instantly and lock in that pricing!"
  • "GLP-1 with Locked-In Flat Pricing for Life" is the homepage headline, but the only thing the pricing table locks is the term you commit to
  • No compounding pharmacy is named — only "U.S.-based 503A compounding pharmacies" — and no full state list is published
  • Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Visit SnagRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

SnagRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Where this sits

#25 of 548

Ordered with the companies that pay us first, and SnagRx is one of them. A disclosed partition, not a score.

Compare all 548 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with SnagRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

bmiMD

$159/mo microdose — same as its full dose

Vs median
$16/mo below the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Same price at every dose
Dispensed
Pharmacy not publicly identified
Visit bmiMD

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the bmiMD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.